title: Current Status of Immunotherapy Treatments for Pancreatic Cancer.
abstract: Pancreatic cancer (PC) is a lethal disease representing the seventh most frequent cause of death from cancer worldwide. Resistance of pancreatic tumors to current treatments leads to disappointing survival rates, and more specific and effective therapies are urgently needed. In recent years, immunotherapy has been proposed as a promising approach to the treatment of PC, and encouraging results have been published by various preclinical and clinical studies. This review provides an overview of the latest developments in the immunotherapeutic treatment of PC and summarizes the most recent and important clinical trials.
authors: *Institute of Biopathology and Regenerative Medicine (IBIMER) ‡Department of Biochemistry and Molecular Biology I, Universidad de Granada, Granada †Department of Health Sciences, Universidad de Jaen, Jaen, Spain.
authors: Cristina
authors: C
authors: Jimenez-Luna
authors: Jose
authors: J
authors: Prados
authors: Raul
authors: R
authors: Ortiz
authors: Consolacion
authors: C
authors: Melguizo
authors: Carolina
authors: C
authors: Torres
authors: Octavio
authors: O
authors: Caba
mesh_terms: D006801:Humans; D007167:Immunotherapy; D010190:Pancreatic Neoplasms / Q000628:therapy*